跳至主要内容
临床试验/JPRN-jRCTs051210137
JPRN-jRCTs051210137招募中未知

Assessment of coagulation potential of concomitantly used factor VIII concentrates in hemophilia A patients with emicizumab prophylaxis - CAGUYAMA Study

ogami Keiji0 个研究点目标入组 100 人开始时间: 2021年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 4age old 至 ot applicable(—)
性别
Male

入选标准

  • 1)Congenital hemophilia A patients without inhibitor over 4 years old
  • 2)Patients receiving emicizumab 5 times or more based on the latest package insert
  • 3)Patients who have received sufficient explanation about the contents of this clinical study, and have obtained written consent from the study patients or their legal guardian
  • 4)Patients who can comply with the planned procedure in this clinical study

排除标准

  • 1)Patients who have difficulty in regular visits and/or visits at the events
  • 2)Patients with other diseases with abnormal liver function or platelet count (AST and/or ALT are 5 times or more of the normal upper limit. Platelet count<100,000/microliter)
  • 3)Patients with extremely difficult blood collection
  • 4)Patients who are judged by the investigator to be inappropriate for some reasons

研究者

发起方
ogami Keiji

相似试验